Ebit Изменить Дата
Abbott USD 1.36B 775M 2026-09
ANI Pharmaceuticals USD 51.84M 12M 2026-09
Aurora Cannabis CAD -3.17M 10.29M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Canopy Growth CAD -2.03M 143.62M 2026-06
Cara Therapeutics USD -7.05M 1.11M 2026-03
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 13.09B 635M 2026-09
Novo Nordisk DKK 33.76B 25.86B 2026-06
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 116.6M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
United Therapeutics USD 241.3M 134.3M 2026-09
Xeris Pharmaceuticals USD -24.15M 33.27M 2026-06